UBS


Good Q3 figures, earnings much better than expected

30/10/24 -"• Revenues were up by 5% to $12.3bn for the Q3 24 compared to Q3 23 • Total operating expenses declined by 12% to $10.3bn for the Q3 24 versus Q3 23. • Net result attributable to shareholders ..."

Pages
53
Language
English
Published on
30/10/24
You may also be interested by these reports :
26/06/26
In our previous idea kicker on ABN Amro (REDUCE;Netherlands), back in October 2024, we acknowledged ABN’s progress made under its previous 2021-2024 ...

24/06/26
The unexpected success of UCG’s offer is likely to result in a takeover of CBK. Although the capital impact appears manageable, the cost of capital ...

17/06/26
We have upgraded our 2026 and 2027 EPS projections (+25% for both years vs our previous respective estimates). Our positive revision stems mainly ...

15/06/26
DWS (ADD; Germany) is one of the leading retail asset managers in Europe (with a record €1,085bn in AuM at the end of 2025, reaching €1,093bn by the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO